Characteristics of the whole cohort and of patients with DVT/PE and with CVT
| . | All (n = 784) . | Any thrombosis (n = 112) . | DVT/PE (n = 85) . | CVT (n = 32) . |
|---|---|---|---|---|
| Age, median (IQR), y | 36 (25-48) | 39 (28-51) | 39 (28-51) | 38 (23-43) |
| Female, n (%) | 312 (40) | 54 (48) | 39 (46) | 16 (50) |
| BMI, median (IQR), kg/m2 | 24 (21-27) | 25 (22-28) | 25 (22-28) | 23 (21-26) |
| Smoking, n (%) | ||||
| No | 396 (50) | 63 (56) | 49 (58) | 16 (50) |
| Yes | 226 (29) | 28 (25) | 21 (25) | 10 (31) |
| Missing data | 162 (21) | 21 (19) | 15 (17) | 6 (19) |
| Contraception, n (%) | ||||
| No | 124 (16) | 24 (21) | 17 (20) | 8 (25) |
| Yes | 78 (10) | 13 (12) | 10 (12) | 3 (9) |
| Missing data | 110 (14) | 17 (15) | 12 (14) | 5 (16) |
| Not applicable | 472 (60) | 58 (52) | 46 (54) | 16 (50) |
| Phenotype, n (%) | ||||
| B-cell | 523 (67) | 70 (63) | 52 (61) | 20 (63) |
| T-cell | 261 (33) | 42 (37) | 33 (39) | 12 (38) |
| CNS involvement, n (%) | 55 (7) | 5 (5) | 3 (4) | 2 (6) |
| WBC count at diagnosis, median (IQR), G/l | 12 (4-42) | 13 (4-47) | 13 (4-49) | 14 (3-51) |
| Hemoglobin level at diagnosis, median (IQR), g/dL | 10 (8-12) | 11 (9-13) | 10 (8-12) | 12 (10-14) |
| Platelet count at diagnosis, median (IQR), G/l | 72 (32-154) | 89 (40-196) | 94 (32-207) | 84 (56-167) |
| Prothrombin ratio at diagnosis, median (IQR) | 82 (72-92) | 85 (73-92) | 85 (74-92) | 85 (71-90) |
| Fibrinogen level at diagnosis, median (IQR), g/L | 4 (3-5) | 4 (3-5) | 4 (3-6) | 4 (2-6) |
| Poor early PB blast clearance, n (%) | 184 (24) | 19 (17) | 15 (18) | 4 (13) |
| . | All (n = 784) . | Any thrombosis (n = 112) . | DVT/PE (n = 85) . | CVT (n = 32) . |
|---|---|---|---|---|
| Age, median (IQR), y | 36 (25-48) | 39 (28-51) | 39 (28-51) | 38 (23-43) |
| Female, n (%) | 312 (40) | 54 (48) | 39 (46) | 16 (50) |
| BMI, median (IQR), kg/m2 | 24 (21-27) | 25 (22-28) | 25 (22-28) | 23 (21-26) |
| Smoking, n (%) | ||||
| No | 396 (50) | 63 (56) | 49 (58) | 16 (50) |
| Yes | 226 (29) | 28 (25) | 21 (25) | 10 (31) |
| Missing data | 162 (21) | 21 (19) | 15 (17) | 6 (19) |
| Contraception, n (%) | ||||
| No | 124 (16) | 24 (21) | 17 (20) | 8 (25) |
| Yes | 78 (10) | 13 (12) | 10 (12) | 3 (9) |
| Missing data | 110 (14) | 17 (15) | 12 (14) | 5 (16) |
| Not applicable | 472 (60) | 58 (52) | 46 (54) | 16 (50) |
| Phenotype, n (%) | ||||
| B-cell | 523 (67) | 70 (63) | 52 (61) | 20 (63) |
| T-cell | 261 (33) | 42 (37) | 33 (39) | 12 (38) |
| CNS involvement, n (%) | 55 (7) | 5 (5) | 3 (4) | 2 (6) |
| WBC count at diagnosis, median (IQR), G/l | 12 (4-42) | 13 (4-47) | 13 (4-49) | 14 (3-51) |
| Hemoglobin level at diagnosis, median (IQR), g/dL | 10 (8-12) | 11 (9-13) | 10 (8-12) | 12 (10-14) |
| Platelet count at diagnosis, median (IQR), G/l | 72 (32-154) | 89 (40-196) | 94 (32-207) | 84 (56-167) |
| Prothrombin ratio at diagnosis, median (IQR) | 82 (72-92) | 85 (73-92) | 85 (74-92) | 85 (71-90) |
| Fibrinogen level at diagnosis, median (IQR), g/L | 4 (3-5) | 4 (3-5) | 4 (3-6) | 4 (2-6) |
| Poor early PB blast clearance, n (%) | 184 (24) | 19 (17) | 15 (18) | 4 (13) |